Matsuda Junya, Kitamura Mitsunobu, Takayama Morimasa, Imori Yoichi, Shibuya Junsuke, Kubota Yoshiaki, Sangen Hideto, Nakamura Shunichi, Takano Hitoshi, Asai Kuniya, Shimizu Wataru
Department of Cardiovascular Medicine, Nippon Medical School Hospital, Sendagi 1-1-5, Bunkyo, Tokyo, 113-8603, Japan.
Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
Heart Vessels. 2018 Mar;33(3):246-254. doi: 10.1007/s00380-017-1053-9. Epub 2017 Sep 30.
After alcohol septal ablation (ASA), regression of left ventricular hypertrophy (LVH) has been observed in several studies using echocardiography or cardiac magnetic resonance, and favorable changes of myocardial excitation have been expected. However, no studies have focused on the alteration of electrocardiography (ECG) findings after ASA. Therefore, we evaluated serial changes in ECG parameters during the chronic phase after ASA for drug-refractory hypertrophic obstructive cardiomyopathy (HOCM). From 1998 to 2014, we performed 187 ASA procedures in 157 drug-refractory HOCM patients. After excluding patients who underwent dual-chamber pacing therapy and who underwent staged or repeat ASA within 2 years after the index ASA, 25 patients without bundle branch block and additional pacemaker implantation were enrolled in the main study group. ECGs, echocardiograms, and clinical follow-up data were evaluated at baseline and, 1, 6, 12, and 24 months after ASA. Patients with bundle branch block or additional pacemaker implantation were assigned in a referential group (n = 79), in which the echocardiographic changes between baseline and at 1 year were evaluated. Sokolow-Lyon index (SLi), Cornell index, and total 12-lead QRS amplitude significantly decreased during 2-year follow-up after ASA. SLi and Cornell index significantly decreased from 6 to 12 months (p < 0.05 vs. p < 0.01). Changes in SLi were significantly associated with changes in the interventricular septal thickness (r = 0.54, p < 0.005), left ventricular mass index (r = 0.40, p = 0.050), and peak creatine phosphokinase level (r = -0.41, p = 0.042), but not in the Cornell index and 12-lead QRS amplitude. In the comparison between baseline and at 1 year, significant improvements in the interventricular septal thickness, posterior wall thickness, left atrial size, E/A ratio, and E/e' were observed in the echocardiographic study. Changes of SLi reflected regression of LVH after ASA with the best correlation. During the chronic phase after ASA, LVH regression was confirmed by echocardiographic and ECG parameters.
在酒精间隔消融术(ASA)后,多项使用超声心动图或心脏磁共振成像的研究观察到左心室肥厚(LVH)有所消退,并预期心肌兴奋会发生有利变化。然而,尚无研究关注ASA后心电图(ECG)表现的改变。因此,我们评估了药物难治性肥厚性梗阻性心肌病(HOCM)患者在ASA后慢性期ECG参数的系列变化。1998年至2014年,我们对157例药物难治性HOCM患者实施了187例ASA手术。在排除接受双腔起搏治疗以及在首次ASA后2年内接受分期或重复ASA的患者后,25例无束支传导阻滞且未植入额外起搏器的患者被纳入主要研究组。在基线以及ASA后1、6、12和24个月对ECG、超声心动图和临床随访数据进行评估。有束支传导阻滞或植入额外起搏器的患者被分配到参照组(n = 79),评估该组基线与1年时的超声心动图变化。在ASA后的2年随访期间,索科洛 - 里昂指数(SLi)、康奈尔指数和12导联QRS波总振幅显著降低。SLi和康奈尔指数在6至12个月时显著降低(分别为p < 0.05和p < 0.01)。SLi的变化与室间隔厚度变化(r = 0.54,p < 0.005)、左心室质量指数变化(r = 0.40,p = 0.050)以及肌酸磷酸激酶峰值水平变化(r = -0.41,p = 0.042)显著相关,但与康奈尔指数和12导联QRS波振幅变化无关。在超声心动图研究中,与基线相比,1年时观察到室间隔厚度、后壁厚度、左心房大小、E/A比值和E/e'有显著改善。SLi的变化反映了ASA后LVH的消退,相关性最佳。在ASA后的慢性期,通过超声心动图和ECG参数证实了LVH的消退。